HCPCS Level IIdrugActive
J1306
Injection, inclisiran, 1 mg
BETOS: O1E
Effective: 2022-07-01
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Leqvio
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
1 MG
Billing Units
284.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.
Coverage Policies
No coverage policies currently reference this code